Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
| Episode | Date |
|---|---|
|
Carfilzomib-lenalidomide maintenance extends PFS, not OS
|
Nov 18, 2026 |
|
ALL MRD consensus: marrow as reference, MRD over morphology
|
Nov 11, 2026 |
|
Early HL, no RT: worse PFS if bulky or interim PET-positive
|
Nov 04, 2026 |
|
Mitapivat raises haemoglobin in sickle cell, not pain crises
|
Oct 28, 2026 |
|
Ponatinib-blinatumomab lifts 2-year EFS to 86% in Ph+ ALL
|
Oct 21, 2026 |
|
Venetoclax tied to lower AML mortality, not after MDS/MPN
|
Oct 14, 2026 |
|
Ibrutinib-venetoclax roughly halves death risk in CLL
|
Oct 07, 2026 |
|
Nivolumab-AVD vs BV-AVD in Hodgkin: comparable survival
|
Sep 30, 2026 |
|
TKI plus chemo in BCR::ABL1+ AML tied to ~90% remission
|
Sep 23, 2026 |
|
Mitapivat cuts transfusion burden in thalassaemia
|
Sep 16, 2026 |
|
Ven-aza matches cytarabine salvage in relapsed AML
|
Sep 09, 2026 |
|
Voxelotor lowers CBFV in SCD kids, but 8 vs 2 deaths
|
Sep 02, 2026 |
|
Daratumumab-Rd extends myeloma survival to 90 vs 64 months
|
Aug 26, 2026 |
|
Eltrombopag improves cyclosporine response in moderate AA
|
Aug 19, 2026 |
|
This Week in Hematology — Aug 12, 2026
|
Aug 12, 2026 |
|
Bevacizumab tied to fewer transfusions in angiodysplasia
|
Aug 06, 2026 |
|
This Week in Hematology — Jul 31, 2026
|
Jul 31, 2026 |
|
This Week in Hematology — Jul 22, 2026
|
Jul 22, 2026 |
|
This Week in Hematology — Jul 15, 2026
|
Jul 15, 2026 |
|
This Week in Hematology — Jul 8, 2026
|
Jul 08, 2026 |
|
This Week in Hematology — Jul 1, 2026
|
Jul 01, 2026 |
|
This Week in Hematology — Jun 24, 2026
|
Jun 25, 2026 |
|
This Week in Hematology — Jun 17, 2026
|
Jun 18, 2026 |
|
This Week in Hematology — Jun 10, 2026
|
Jun 11, 2026 |
|
This Week in Hematology — Jun 4, 2026
|
Jun 05, 2026 |
|
This Week in Hematology — May 28, 2026
|
May 28, 2026 |
|
This Week in Hematology — May 21, 2026
|
May 21, 2026 |
|
This Week in Hematology — May 14, 2026
|
May 14, 2026 |